Drugs / Lopinavir/Ritonavir
last change Jan 2009 re-read 2 minutes ago

Lopinavir/Ritonavir

Developed for
HIV infectious disease

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
NCT00255840 Comparator Jul 2006 → Jan 2009 HIV infectious disease CIPRA SA Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Lopinavir/Ritonavir ClinicalTrials.gov intervention name — accepted as the source's own label NCT00255840
Route Oral “400 mg lopinavir/100mg ritonavir tablet taken orally twice daily” NCT00255840